During the past decade, Chu de Grenoble-Hopital Sud conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chu de Grenoble-Hopital Sud" #1 sponsor was "Jazz Pharmaceuticals" with 2 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Ipsen" with 1 trials sponsored, "Otto Bock France SNC" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chu de Grenoble-Hopital Sud" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Chu de Grenoble-Hopital Sud" are "Fibromyalgia" (2 trials), "Rheumatoid Arthritis" (2 trials), "Amputation of Hip and Thigh, Level Unspecified" (1 trials), "Ankylosing Spondylitis" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Chu de Grenoble-Hopital Sud" in a lesser frequency.

Most popular intervention types in "Chu de Grenoble-Hopital Sud" are "Drug" (3 trials), "Device" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Xyrem®" (2 trials), "3C60-NMPK" (1 trials), "AboBoNT-A" (1 trials), "Baricitinib" (1 trials) and "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chu de Grenoble-Hopital Sud" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Chu de Grenoble-Hopital Sud". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Chu de Grenoble-Hopital Sud, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chu de Grenoble-Hopital Sud, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".